RNA extraction kits market to reach $3.68 billion by 2030

The global RNA extraction kits market is projected to grow from $2.27 billion in 2025 to $3.68 billion by 2030 as genomics, infectious disease testing and precision medicine expand. North America led in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - RNA extraction kits sit at the front end of molecular testing, so demand rises as diagnostics, genomics and transcriptomics expand. - The market’s projected climb to $3.68 billion by 2030 points to sustained spending on lab tools that support gene expression analysis, sequencing and disease detection. - Faster adoption of precision medicine, decentralized testing and automated workflows could reshape how labs process samples.

What happened: - The Business Research Company projected the global RNA extraction kits market will increase from $2.27 billion in 2025 to $2.51 billion in 2026. - The report pegs 2025-2026 growth at a 10.5% CAGR. - The market is forecast to reach $3.68 billion by 2030, reflecting a 10.1% CAGR from 2026 to 2030. - The report covers market size, trends and forecasts for 2026-2035. - The company also released a free sample of the report and a full market report.

The details: - RNA extraction kits isolate and purify RNA from biological samples using chemical reagents and purification components. - The kits are used to improve RNA quality, purity and stability for molecular analysis. - They support downstream uses such as gene expression profiling and molecular characterization. - Market growth has been driven by broader use of molecular diagnostics in clinical labs. - Demand has also increased with growth in genomic and transcriptomic research. - Infectious and genetic disorders that require RNA analysis have added to kit usage. - Pharmaceutical research and development has increased demand for RNA preparation tools. - Labs have also standardized nucleic acid extraction procedures, supporting wider adoption. - The report highlights automated, high-throughput RNA isolation systems for large molecular workflows. - It also flags contamination-free extraction methods that can improve sequencing accuracy. - Microfluidic platforms, portable molecular extraction kits, spin column methods and magnetic bead methods are among the technologies shaping the market.

Between the lines: - The market outlook reflects a shift from basic extraction toward faster, cleaner and more automated sample prep. - The strongest demand appears tied to workflows that need higher throughput and better accuracy, especially as NGS expands. - Genomic research momentum is still building; ASGCT reported Phase II gene therapies increased from 247 in Q1 2023 to 260 in Q2 2023. - Infectious disease pressure remains another tailwind; CDC data showed U.S. tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023. - North America held the largest market share in 2025 because of strong adoption and advanced healthcare infrastructure. - Asia-Pacific is expected to grow fastest as research activity, healthcare investment and diagnostic demand rise.

What's next: - Precision medicine and personalized treatment programs are likely to keep pushing RNA testing demand higher. - Next-generation sequencing applications should expand the need for high-quality RNA extraction. - Automation in sample preparation may become a competitive focus for kit makers. - Decentralized and point-of-care testing could open more demand for portable extraction products. - The report says future editions will include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards and market hotspots infographics.

The bottom line: - RNA extraction kits are moving from a niche lab consumable to a core enabling technology for diagnostics and genomics, with double-digit growth still ahead.